Back to search
Antibody Mediated Rejection of Lung Transplant
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Antibody Mediated Rejection of Lung Transplant trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Antibody Mediated Rejection of Lung Transplant trials you may qualify forAntibody-mediated rejection after lung transplantation commonly results in allograft failure and death in spite of current therapeutic regimens. We are testing…
Objective: To evaluate the potential impact of molecular phenotyping of transbronchial biopsies in lung transplant recipients with allograft dysfunction, and th…
The goal of this clinical trial is to evaluate the therapeutic effect of extracorporeal photopheresis in subclinical antibody-mediated rejection after lung tran…
Background: People who have lung transplants often survive 6 or 7 years. But some people develop donor-specific antibodies (DSA) after their transplants; antib…
With this project, the research team aims to identify the molecular pathways associated with the response to extracorporeal photonchemioapheresis (ECP) in kidne…
The aim is to compare the quantitative parameters of de novo anti-HLA DQ Donor Specific Antibodies (DSA), determined at the time of their discovery by surface p…